Producto añadido correctamente al carrito.

Octreotide
Ver en 3D

Biosynth logo

Octreotide

CAS: 83150-76-9

Ref. 3D-IDA15076

1mgDescatalogado
5mgDescatalogado
10mg
Descatalogado
25mg
Descatalogado
50mg
Descatalogado
0.01gDescatalogado
100mg
Descatalogado
250mg
Descatalogado
0.025gDescatalogado

Producto descatalogado. Para consultas sobre productos similares, rellene nuestro formulario o envíenos un correo electrónico a .


Información del producto

Nombre:
Octreotide
Sinónimos:
  • L-cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl) propyl)-cyclic (2->7)-disulfide, (R-(R*,R*))
  • OctreotideAcetate
  • 10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate (1:2)
  • (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
  • (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
  • 1: PN: EP1118336 SEQID: 1 claimed protein
  • 11: PN: US20030229017 PAGE: 13 claimed protein
  • 14: PN: DE10147056 PAGE: 40 claimed protein
  • 17: PN: US6268342 SEQID: 18 claimed protein
  • 25: PN: WO2007081792 SEQID: 40 claimed protein
  • Ver más sinónimos
  • L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
  • Longastatin
  • Sms 201-995
Descripción:

Octreotide is a drug that is used to treat carcinoid syndrome, a condition characterized by excessive production of hormones and neurotransmitters such as serotonin. It works by inhibiting the release of these substances from the cells in the body. Octreotide also has been shown to have some effect on somatostatin receptors, which are found in the hypothalamus and brain. This drug binds to these receptors and inhibits the release of growth hormone, prolactin, and other hormones. Octreotide has also been shown to be effective against bowel disease in experimental models. Octreotide can cause adverse effects such as nausea, vomiting, diarrhea, headache, injection site reactions (e.g., pain), and skin reactions (e.g., rash).

Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:

Propiedades químicas

Peso molecular:
1,019.24 g/mol
Fórmula:
C49H66N10O10S2
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:

Información de peligrosidad

Número UN:
Cantidad exceptuada (EQ):
Clase:
Frases H:
Frases P:
Prohibido volar:
Información de peligrosidad:
Grupo de empaquetado:
Cantidad limitada (LQ):

Consulta sobre el producto descatalogado: 3D-IDA15076 Octreotide

* Campos obligatorios
¡Bienvenido a CymitQuimica!Utilizamos cookies para mejorar su visita. No incluimos publicidad.

Consulte nuestra Política de Cookies para obtener más información o ajuste sus preferencias en "Configurar".